• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

GSK

GSK booth at ASCO 2026
Manufacturing

GSK to shutter flu vaccine manufacturing site

GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.
Ben Adams Sep 14, 2026 9:46am
GSK

GSK prepares frontline FDA bid for lung cancer drug Jideytro

Sep 13, 2026 7:00pm
Asia

Roche, GSK, Novartis, MFN, Akeso and more—Fierce Pharma Asia

Sep 4, 2026 8:52am
Asia

Roche-Hanmi, Akeso, a congressman's concerns—Fierce Pharma Asia

Aug 28, 2026 9:00am
Miels

GSK CEO targets mature products, procurement for cost savings

Jul 28, 2026 9:45am
Podcast
Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b

GSK’s first lung cancer approval, a new IPO path and more

Jul 24, 2026 9:42am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings